[Source: Medical News Today]
A report in the September 21 issue of JAMA suggests that, children and teens who have obsessive-compulsive disorder (OCD) who received some benefit from therapy with medication had a considerably larger reduction in OCD symptoms when treatment was combined with cognitive behavior therapy.
According to background data in the report:
“Obsessive-compulsive disorder affects up to 1 in 50 people, is evident across development, and is associated with substantial dysfunction and psychiatric comorbidity. Randomized controlled trial findings support the efficacy of pharmacotherapy with serotonin reuptake inhibitors (SRIs), cognitive behavior therapy [CBT] involving exposure plus response prevention, and combined treatment. However, a paucity of expertise in pediatric OCD prevents most families from accessing exposure plus response prevention or combined treatment. Outcome data for pharmacotherapy alone, the most widely available treatment indicate that partial response is the norm and clinically significant residual symptoms often persist even after an adequate trial.”
Read the Rest of this Article on Medical News Today